Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 4 results.
User Information
Export Records
  1. 1.   Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms
  2. Tan, A. R.; Headlee, D.; Messmann, R.; Sausville, E. A.; Arbuck, S. G.; Murgo, A. J.; Melillo, G.; Zhai, S. P.; Figg, W. D.; Swain, S. M.; Senderowicz, A. M.
  3. Journal of Clinical Oncology. 2002 20(19): 4074-4082.
  1. 2.   Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of ras via a histidine protein kinase pathway
  2. Hartsough, M. T.; Morrison, D. K.; Salerno, M.; Palmieri, D.; Ouatas, T.; Mair, M.; Patrick, J.; Steeg, P. S.
  3. Journal of Biological Chemistry. 2002 277(35): 32389-32399.
  1. 3.   Flavopiridol Induces Apoptosis of Normal Lymphoid Cells, Causes Immunosuppression, and Has Potent Antitumor Activity in Vivo Against Human Leukemia and Lymphoma Xenografts
  2. Arguello, F.; Alexander, M.; Sterry, J. A.; Tudor, G.; Smith, E. M.; Kalavar, N. T.; Greene, J. F.; Koss, W.; Morgan, C. D.; Stinson, S. F.; Siford, T. J.; Alvord, W. G.; Klabansky, R. L.; Sausville, E. A.
  3. Blood. 1998 91(7): 2482-2490.
  1. 4.   Determination of Flavopiridol (L86 8275 Nsc 649890) in Human Plasma By Reversed-Phase Liquid Chromatography With Electrochemical Detection
  2. Stinson, S. F.; Hill, K.; Siford, T. J.; Phillips, L. R.; Daw, T. W.
  3. Cancer Chemotherapy and Pharmacology. 1998 42(4): 261-265.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel